中南医学科学杂志2024,Vol.52Issue(4) :685-688.DOI:10.15972/j.cnki.43-1509/r.2024.04.046

HBP、SAA、nCD64在颅内感染早期诊疗中作用的研究进展

Research progress on the role of HBP,SAA,and nCD64 in the early diagnosis and treatment of intracranial infection

赵亚宁 胡涛 王一鸣 任子阳 陈胜利
中南医学科学杂志2024,Vol.52Issue(4) :685-688.DOI:10.15972/j.cnki.43-1509/r.2024.04.046

HBP、SAA、nCD64在颅内感染早期诊疗中作用的研究进展

Research progress on the role of HBP,SAA,and nCD64 in the early diagnosis and treatment of intracranial infection

赵亚宁 1胡涛 1王一鸣 1任子阳 1陈胜利1
扫码查看

作者信息

  • 1. 山西医科大学第五临床医学院神经外科,山西太原 030012
  • 折叠

摘要

开颅术后颅内感染是神经外科的严重并发症,其致残、致死率均较高.临床常规检测颅内感染指标的特异性、敏感性不足,脑脊液细菌培养耗时且阳性率低.近年来,肝素结合蛋白(HBP)、血清淀粉样蛋白A(SAA)、中性粒细胞CD64(nCD64)作为新型感染标志物,在敏感性、特异性方面具有独特优势,并且检测方法简便快捷,在感染诊断、疗效评估、预后判断等方面具有广泛的临床应用前景.本文从HBP、SAA、nCD64在颅内感染早期中的诊断价值、临床应用及检测方法等方面进行综述.

Abstract

Post-craniotomy intracranial infection is a serious complication in neurosurgery,with high rates of disability and mor-tality.The specificity and sensitivity of routine clinical detection of intracranial infection indicators were insufficient,and cerebrospi-nal fluid bacterial culture was time-consuming and had a low positive rate.In recent years,heparin binding protein(HBP),serum amyloid A(SAA),and neutrophil CD64 have unique advantages in sensitivity and specificity as novel infection markers,and their de-tection methods were simple and fast.They have broad clinical application prospects in infection diagnosis,efficacy evaluation,prog-nosis judgment,and other aspects.This article reviews the diagnostic value,clinical application,and detection methods of HBP,SAA,and nCD64 in the early stage of intracranial infection.

关键词

肝素结合蛋白/血清淀粉样蛋白A/中性粒细胞CD64/颅内感染/早期诊疗

Key words

HBP/SAA/nCD64/intracranial infection/early diagnosis and treatment

引用本文复制引用

基金项目

山西省医学重点科研项目(2023XM030)

山西省基础研究计划项目(202203021211057)

出版年

2024
中南医学科学杂志
南华大学

中南医学科学杂志

CSTPCD
影响因子:0.757
ISSN:2095-1116
参考文献量15
段落导航相关论文